Ben Lomond, CA, United States of America

Brian Troy Frederick

This inventor holds 29 USPTO granted patents and 26 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Peptide Inhibitors. Top assignees: Protagonist Therapeutics, Inc., Janssen Biotech, Inc., Affymax, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian Troy Frederick. Retrieved from https://idiyas.com/inventor/brian-troy-frederick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 

% Patents Active = 96.6

 

 

Average Co-Inventor Count = 6.2

ph-index = 13

Forward Citations = 310(Granted Patents)


Location History:

  • Ben Lomond, CA (US) (2012 - 2023)
  • Ben Lomand, CA (US) (2018 - 2024)
  • Newark, CA (US) (2023 - 2024)

Company Filing History:


Years Active: 2012-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Peptide Inhibitors
Interleukin-23
Inflammatory Bowel Diseases
Hepcidin Analogues
Opioid Agonist Peptides
Thioether Peptide Dimer
Conjugated Mimetics
Nitrogen-Based Linkers
Inflammatory Diseases
Analogues
Oral Peptides
Macromolecules
29 patents (USPTO):Explore Patents

Title: The Innovative Mind of Brian Troy Frederick

Introduction

Brian Troy Frederick, hailing from Ben Lomond, California, is a distinguished inventor with an impressive portfolio of 25 patents. His work primarily revolves around advancements in pharmacological innovations, particularly focusing on therapeutic applications that address critical health challenges.

Latest Patents

Among his latest contributions to the field are two notable patents. The first is for "Conjugated Hepcidin Mimetics," which provides hepcidin analogues with improved in vivo half-lives, along with related pharmaceutical compositions and methods of use. The second patent addresses "Peptide Inhibitors of Interleukin-23 Receptor and Their Use to Treat Inflammatory Diseases," which presents novel peptide inhibitors designed to treat or prevent various diseases, including inflammatory bowel diseases.

Career Highlights

Brian has made significant strides in his career by collaborating with prominent companies such as Protagonist Therapeutics, Inc. and Janssen Biotech, Inc. His role within these organizations has played a crucial part in advancing therapeutic innovations, showcasing his expertise and commitment to improving healthcare through innovative solutions.

Collaborations

Throughout his career, Brian has worked alongside notable colleagues, including Ashok Bhandari and Gregory Thomas Bourne. These collaborations have fostered a stimulating environment conducive to innovation, enabling the development of groundbreaking therapeutic approaches.

Conclusion

In summary, Brian Troy Frederick's contributions to the field of inventiveness, particularly in pharmacology, are marked by his extensive patent portfolio and collaborative efforts with leading companies and colleagues. His work continues to impact the healthcare industry positively, paving the way for new treatments and advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…